SHC Sotera Health (SHC) Q1 FY26 earnings call
Sotera Health reported a strong first quarter, exceeding expectations with robust constant currency revenue and adjusted EBITDA growth, driven by Sterigenics and Nordion. The company reaffirmed its full-year 2026 outlook, highlighting the resilience of its mission-critical services and strong customer satisfaction. Significant legal progress was made with the dismissal of all eight bellwether personal injury cases in Georgia, reinforcing the company's stance on the safety of its operations. A planned CEO transition was also announced, with the current CEO moving to Executive Chair.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.